Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration.

Department of Internal Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary.
British Journal of Pharmacology (Impact Factor: 5.07). 01/2001; 132(1):101-10. DOI:10.1038/sj.bjp.0703777
Source: PubMed

ABSTRACT 1. The effects of I(Ks) block by chromanol 293B and L-735,821 on rabbit QT-interval, action potential duration (APD), and membrane current were compared to those of E-4031, a recognized I(Kr) blocker. Measurements were made in rabbit Langendorff-perfused whole hearts, isolated papillary muscle, and single isolated ventricular myocytes. 2. Neither chromanol 293B (10 microM) nor L-735,821 (100 nM) had a significant effect on QTc interval in Langendorff-perfused hearts. E-4031 (100 nM), on the other hand, significantly increased QTc interval (35.6+/-3.9%, n=8, P<0.05). 3. Similarly both chromanol 293B (10 microM) and L-735,821 (100 nM) produced little increase in papillary muscle APD (less than 7%) while pacing at cycle lengths between 300 and 5000 ms. In contrast, E-4031 (100 nM) markedly increased (30 - 60%) APD in a reverse frequency-dependent manner. 4. In ventricular myocytes, the same concentrations of chromanol 293B (10 microM), L-735,821 (100 nM) and E-4031 (1 microM) markedly or totally blocked I(Ks) and I(Kr), respectively. 5. I(Ks) tail currents activated slowly (at +30 mV, tau=888.1+/-48.2 ms, n=21) and deactivated rapidly (at -40 mV, tau=157.1+/-4.7 ms, n=22), while I(Kr) tail currents activated rapidly (at +30 mV, tau=35.5+/-3.1 ms, n=26) and deactivated slowly (at -40 mV, tau(1)=641.5+/-29.0 ms, tau(2)=6531+/-343, n=35). I(Kr) was estimated to contribute substantially more to total current density during normal ventricular muscle action potentials (i.e., after a 150 ms square pulse to +30 mV) than does I(Ks). 6. These findings indicate that block of I(Ks) is not likely to provide antiarrhythmic benefit by lengthening normal ventricular muscle QTc, APD, and refractoriness over a wide range of frequencies.

0 0
  • [show abstract] [hide abstract]
    ABSTRACT: The cholesterol-lowering drug, probucol, is known to induce QT interval prolongation and torsades de pointes in patients. Recent in vitro studies have indicated that probucol reduces hERG expression in the plasma membrane and does not directly block human ether-a-go-go-related gene (hERG) channels. The present study was performed to investigate the effects of probucol on in vivo QT interval prolongation. Epicardial electrocardiograms were recorded in conscious dogs given oral single or repeated (7 days) doses of probucol (100mg/kg), and in combination with moxifloxacin (20mg/kg). QTc intervals were analysed by a probabilistic method with individual rate collection formulae. Values of change in QTc ( QTc) interval and its integration from 1 to 21h (AUC1-21h) were calculated to evaluate drug-induced QT prolongation. A single dose of probucol slightly but significantly increased the AUC1-21h QTc interval on days 2 and 3. The QT prolongation was markedly augmented by repeated doses of probucol in a time-dependent manner, despite the lack of increase in plasma concentration. The combination of probucol and moxifloxacin produced additive effects on QT interval prolongation. These results suggest that long-term exposure to the hERG expression inhibitor, probucol, is required to evaluate its maximal effects on in vivo QT interval prolongation. A combination of direct and indirect hERG inhibitors may produce simple additive effects on QT interval prolongation.
    European journal of pharmacology 11/2013; · 2.59 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: Diabetes is associated with an increased risk of sudden cardiac death, but the underlying mechanisms remain unclear. Our goal was to investigate changes occurring in the action potential duration (APD) and conduction velocity (CV) in the diabetic rabbit ventricle, and delineate the principal ionic determinants. A rabbit model of alloxan-induced diabetes was utilized. Optical imaging was used to record electrical activity in isolated Langendorff-perfused hearts in normo-, hypo- and hyper-kalemia ([K(+)]o=4, 2, 12 mM respectively). Patch clamp experiments were conducted to record Na(+) current (INa) in isolated ventricular myocytes. The mRNA/protein expression levels for Nav1.5 (the α-subunit of INa) and connexin-43 (Cx43), as well as fibrosis levels were examined. Computer simulations were performed to interpret experimental data. We found that the APD was not different, but that the CV was significantly reduced in diabetic hearts in normo-, hypo-, and, in hyper-kalemic conditions (13%, 17% and 33% reduction in diabetic vs. control, respectively). The cell capacitance (Cm) was increased (by ~14%), and the density of INa was reduced by ~32% in diabetes compared to controls, but the other biophysical properties of INa were unaltered. The mRNA/protein expression levels for Cx43 were unaltered. For Nav1.5, the mRNA expression was not changed, and though the protein level tended to be less in diabetic hearts, this reduction was not statistically significant. Staining showed no difference in fibrosis levels between the control and diabetic ventricles. Computer simulations showed that the reduced magnitude of INa was a key determinant of impaired propagation in the diabetic ventricle, which may have important implications for arrhythmogenesis.
    Journal of Molecular and Cellular Cardiology 01/2014; · 5.15 Impact Factor
  • Source
    [show abstract] [hide abstract]
    ABSTRACT: The species-specific determinants of repolarization are poorly understood. This study compared the contribution of various currents to cardiac repolarization in canine and human ventricle. Conventional microelectrode, whole-cell patch-clamp, molecular biological and mathematical-modelling techniques were used. Selective IKr-block (50 100 nmol/L dofetilide) lengthened APD90>3-fold more in human than dog, suggesting smaller repolarization-reserve in humans. Selective IK1-block (10-µmol/L BaCl2) and IKs block (1-μmol/L HMR-1556) increased APD90 more in canine than human right-ventricular papillary muscle. Ion-current measurements in isolated cardiomyocytes showed that IK1- and IKs-density were 3- and 4.5-fold larger in dogs than humans respectively. IKr-density and kinetics were similar in human versus dog. ICa and Ito were respectively ~30% larger and ~29% smaller in human, and Na(+),Ca(2+)-exchange current was comparable. Cardiac mRNA-levels for the main IK1 ion-channel subunit Kir2.1 and the IKs accessory-subunit minK were significantly lower, but mRNA-expression of ERG and KvLQT1 (IKr and IKs α-subunits) were significantly higher in human versus dog. Immunostaining suggested lower Kir2.1 and minK, and higher KvLQT1 protein-expression in human versus canine cardiomyocytes. IK1 and IKs inhibition increased the APD-prolonging effect of IKr-block more in dog (by 55% and 51% respectively) than human (33 and 16%), indicating that both currents contribute to increased repolarization-reserve in the dog. A mathematical model incorporating observed human-canine ion-current differences confirmed the role of IK1 and IKs in repolarization-reserve differences. Thus, humans show greater repolarization-delaying effects of IKr-block than dogs, because of lower repolarization-reserve contributions from IK1 and IKs, emphasizing species-specific determinants of repolarization and the limitations of animal models for human disease.
    The Journal of Physiology 08/2013; 591(17):4189-4206. · 4.38 Impact Factor


Available from
Mar 7, 2013